Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New spiroindoline derivatives show potential as remyelinating agents

April 20, 2020

Making neurons from glia alleviates neurodegenerative diseases

April 17, 2020

New RET inhibitors identified at Applied Pharmaceutical Science

April 17, 2020

New histamine H3 receptor antagonists identified at XW Laboratories

April 15, 2020

New N-acetyl-beta-D-glucosaminidase inhibitors identified at Lilly

April 15, 2020

Koselugo receives FDA approval for pediatric patients with NF1-related plexiform neurofibromas

April 14, 2020

Dual mu-opioid/nociceptin receptor agonist BPR-1M97 shows advantages over morphine

April 14, 2020

Focusing on commonalities to fight projected most common cause of death

April 9, 2020

New HDAC6 inhibitors show promise in Charcot-Marie-Tooth disease cell model

April 8, 2020

Kolon begins first-in-human study of KLS-2031 for neuropathic pain from lumbosacral radiculopathy

April 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...